
Guardant Health GH
$ 92.05
2.83%
Annual report 2025
added 02-19-2026
Guardant Health EBITDA per Share 2011-2026 | GH
Annual EBITDA per Share Guardant Health
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.17 | -3.27 | -4.66 | -4.98 | -3.84 | -2.45 | -0.759 | -2.82 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.759 | -4.98 | -3.24 |
Quarterly EBITDA per Share Guardant Health
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.78 | -0.81 | - | -0.87 | -0.74 | -0.73 | - | -0.88 | -1.01 | -1.21 | - | -1.32 | -1.2 | -1.14 | - | -0.9 | -0.91 | -1.02 | - | -0.63 | -0.49 | -0.33 | - | -0.1 | -0.12 | -0.25 | 0.07 | -1.53 | -1.59 | -1.45 | - | -2.06 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.07 | -2.06 | -0.88 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
-4.62 | $ 17.65 | 3.67 % | $ 186 M | ||
|
Agilent Technologies
A
|
5.49 | $ 118.32 | 0.66 % | $ 36 B | ||
|
Medpace Holdings
MEDP
|
19.5 | $ 428.14 | -0.51 % | $ 12.4 B | ||
|
Myriad Genetics
MYGN
|
-3.6 | $ 4.07 | -19.18 % | $ 377 M | ||
|
NeoGenomics
NEO
|
-0.62 | $ 8.89 | 0.28 % | $ 1.14 B | ||
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M | ||
|
National Research Corporation
NRC
|
1.35 | $ 18.05 | -3.68 % | $ 404 M | ||
|
Natera
NTRA
|
-5.33 | $ 217.23 | 5.06 % | $ 21.4 B | ||
|
Koninklijke Philips N.V.
PHG
|
0.61 | $ 27.01 | 2.1 % | $ 20 B | ||
|
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
-0.15 | - | -61.36 % | $ 2.46 M | ||
|
Personalis
PSNL
|
-0.97 | $ 6.05 | 8.72 % | $ 358 M | ||
|
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | ||
|
Soleno Therapeutics
SLNO
|
0.22 | $ 52.93 | 0.01 % | $ 2.69 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
0.00122 | - | - | $ 562 M | ||
|
CareDx, Inc
CDNA
|
-0.3 | $ 21.01 | 1.5 % | $ 1.12 B | ||
|
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-4.41 | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | ||
|
Thermo Fisher Scientific
TMO
|
23.3 | $ 472.7 | 1.27 % | $ 178 B | ||
|
Co-Diagnostics
CODX
|
-36.9 | $ 1.61 | 0.94 % | $ 2.14 M | ||
|
Trinity Biotech plc
TRIB
|
0.08 | $ 0.62 | 2.79 % | $ 61.9 M | ||
|
Castle Biosciences
CSTL
|
0.89 | $ 25.04 | 1.79 % | $ 696 M | ||
|
Twist Bioscience Corporation
TWST
|
-1.86 | $ 59.96 | 5.75 % | $ 3.59 B | ||
|
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
8.64 | $ 185.16 | -0.12 % | $ 9.18 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | ||
|
Waters Corporation
WAT
|
6.02 | $ 351.2 | 2.5 % | $ 20.9 B | ||
|
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | ||
|
Fulgent Genetics
FLGT
|
-1.62 | $ 15.1 | 1.34 % | $ 457 M | ||
|
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
19.2 | $ 124.25 | 2.41 % | $ 10.2 B | ||
|
Illumina
ILMN
|
-3.01 | $ 141.7 | 1.89 % | $ 22.5 B | ||
|
Senseonics Holdings
SENS
|
-1.6 | $ 5.27 | 5.4 % | $ 220 M | ||
|
Interpace Biosciences
IDXG
|
1.02 | $ 2.01 | 0.1 % | $ 8.89 M | ||
|
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
-2.2 | $ 2.16 | -1.14 % | $ 4.96 M | ||
|
Lantheus Holdings
LNTH
|
5.64 | $ 85.5 | -0.37 % | $ 5.77 B | ||
|
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 257.05 | -0.04 % | $ 21.4 B | ||
|
Celcuity
CELC
|
-3.68 | $ 139.73 | -1.38 % | $ 6.53 B | ||
|
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
-4.34 | $ 9.26 | -0.16 % | $ 2.01 B | ||
|
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 189.71 | -0.59 % | $ 21.1 B |